Novartis AG (LON:0K9E)
132.39
+2.07 (1.59%)
At close: Oct 3, 2025
Novartis AG Market Cap
Novartis AG has a market cap or net worth of 190.10 billion as of October 3, 2025. Its market cap has increased by 6.80% in one year.
Market Cap
190.10B
Enterprise Value
209.38B
Revenue
40.28B
Ranking
n/a
PE Ratio
19.07
Stock Price
132.39
Market Cap Chart
Since March 2, 1998, Novartis AG's market cap has increased from 77.31B to 190.10B, an increase of 145.89%. That is a compound annual growth rate of 3.31%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 3, 2025 | 190.10B | 21.67% |
Dec 30, 2024 | 156.24B | -3.94% |
Dec 29, 2023 | 162.64B | 0.78% |
Dec 30, 2022 | 161.38B | 10.87% |
Dec 30, 2021 | 145.56B | -8.09% |
Dec 30, 2020 | 158.37B | -3.22% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 193.12B |
HSBC Holdings | 179.89B |
Shell | 155.21B |
Unilever | 109.14B |
Rolls-Royce Holdings | 97.98B |
British American Tobacco p.l.c. | 84.11B |
Rio Tinto Group | 83.69B |
GSK plc | 66.29B |